Target intelligence / Profile preview

TANGO2 antisense RNA 1 (TANGO2-AS1)

Target
TANGO2-AS1
Molecular classification
Other (putative long non-coding RNA/antisense RNA)
01

Overview

TANGO2 antisense RNA 1 (TANGO2-AS1) would denote a natural antisense transcript (NAT) or long non-coding RNA transcribed from the opposite strand of the TANGO2 locus. Antisense RNAs are often involved in the regulation of their sense gene's expression through mechanisms such as transcriptional interference, modulation of chromatin structure, affecting mRNA stability, or blocking translation[3][6]. However, no peer-reviewed literature, curated gene databases, or clinical resources currently provide evidence that TANGO2-AS1 is a functionally characterized or biologically relevant transcript. There is no validated or widely accepted information available for "TANGO2 antisense RNA 1" as a drug target, gene, or functional entity. Its mention follows gene annotation conventions for antisense RNAs but remains speculative without experimental support. Any future queries or work on this entry should be validated against detailed genomic reference databases or updated literature.

02

Mechanism of action

None described for TANGO2-AS1. For generic antisense RNAs, possible mechanisms (when targeted by antisense oligonucleotides) include: RNase H-mediated degradation of target RNA; Blocking of translation or splicing.

03

Biological functions

Unknown for TANGO2-AS1 specifically.Regulation of gene expression (transcriptional interference, mRNA stability, chromatin remodeling)
04

Disease associations

Unknown for TANGO2-AS1 specifically.No data link it to any particular disease context.

Beyond the preview

Go deeper on TANGO2 antisense RNA 1 (TANGO2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TANGO2 antisense RNA 1 (TANGO2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call